Oral Medicines for Children in the European Paediatric Investigation Plans

INTRODUCTION: Pharmaceutical industry is no longer allowed to develop new medicines for use in adults only, as the 2007 Paediatric Regulation requires children to be considered also. The plans for such paediatric development called Paediatric Investigation Plans (PIPs) are subject to agreement by th...

Descripción completa

Detalles Bibliográficos
Autores principales: van Riet – Nales, Diana A., Römkens, Erwin G. A. W., Saint-Raymond, Agnes, Kozarewicz, Piotr, Schobben, Alfred F. A. M., Egberts, Toine C. G., Rademaker, Carin M. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045729/
https://www.ncbi.nlm.nih.gov/pubmed/24897509
http://dx.doi.org/10.1371/journal.pone.0098348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045729/
https://www.ncbi.nlm.nih.gov/pubmed/24897509
http://dx.doi.org/10.1371/journal.pone.0098348

Ejemplares similares